Posts about:
Welcome back to our enlightening series on Schizophrenia. In this third entry, we're going to delve even deeper into the intricacies of this complex mental health condition. This blog is dedicated to clearing up common misconceptions, shedding light on lesser-known facts, and continuing our journey towards understanding and empathy.
Welcome to our Blog Series about Schizophrenia! Schizophrenia is a complex and often misunderstood mental health condition that affects millions of people around the world. Despite its prevalence, many people still hold misconceptions about schizophrenia and the people who live with it.
This series of blogs explores the realities of schizophrenia, dispelling common myths, and providing information and resources to those who need it. Whether you or someone you know has been diagnosed with schizophrenia, or you simply want to learn more about this condition, this series is for you.
Psychedelics have been used for centuries in spiritual and medicinal settings, but only recently have they begun to gain acceptance in the scientific community. Research on psychedelics such as LSD, psilocybin, and MDMA is expanding rapidly, with promising findings in treatments for mental health disorders like depression, anxiety, and PTSD, to name a few.
Clinical research is how all treatments reach patients, including medications to treat mental illnesses. All medications currently on the market went through the rigorous stages of the clinical research funnel, and many more are currently being researched. To date, Segal Trials has 57 medications and devices that are approved by the U.S. Food and Drug Administration (FDA). That’s 57 treatments changing the lives of millions of patients.
Clinical studies found psychedelic drugs such as lysergic acid diethylamide (LSD) may be effective at reducing symptoms of anxiety, learn the facts.